Toggle navigation
Home
Search
Services
Blog
Contact
About
Independent and Coordinate Regulation of IL3 and Gmcsf
Taylor, Douglas S.
Dana-Farber Cancer Institute, Boston, MA, United States
Search 43 grants from Douglas Taylor
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Adhesion of Leptospira interrogans to Human Cell Surface Receptors
Structure and Function of the Platelet Membrane Glycoprotein Iib-Iiia Complex
Cost-Effectiveness of Breast Cancer Screening Promotion Programs
Molecular Mechanisms of Transcriptional Initiation and Activation
Gi Myoelectric Activity - Maturation and Function
Recently added grants:
Patient-centered mobile technology interventions to improve maternal health in Uganda
A New Strategy to Increase Proteotoxic Cell Death in Hepatocellular Carcinoma
Optimizing sleep spindle measurements as translational assays of memory consolidation
Molecular mechanistic studies of long ?noncoding? RNAs in mammalian cell differentiation
MUSC Post-Baccalaureate Research Education Program
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08HL003483-01
Application #
2211750
Study Section
Research Training Review Committee (RTR)
Project Start
1996-02-01
Project End
2001-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Related projects
NIH 1999
K08 HL
Independent and Coordinate Regulation of IL3 and Gmcsf
Taylor, Douglas S. / Dana-Farber Cancer Institute
NIH 1998
K08 HL
Independent and Coordinate Regulation of IL3 and Gmcsf
Taylor, Douglas S. / Dana-Farber Cancer Institute
NIH 1997
K08 HL
Independent and Coordinate Regulation of IL3 and Gmcsf
Taylor, Douglas S. / Dana-Farber Cancer Institute
NIH 1996
K08 HL
Independent and Coordinate Regulation of IL3 and Gmcsf
Taylor, Douglas S. / Dana-Farber Cancer Institute
Publications
Taylor, D S; Lee, Y; Sieff, C A et al.
(1998)
Phase I/II trial of PIXY321 (granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein) for treatment of inherited and acquired marrow failure syndromes.
Br J Haematol 103:304-7
Comments
Be the first to comment on Douglas Taylor's grant